Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The piperidine nitroxide Tempol potentiates the cytotoxic effects of temozolomide in human glioblastoma cells.

Ravizza R, Cereda E, Monti E, Gariboldi MB.

Int J Oncol. 2004 Dec;25(6):1817-22.

PMID:
15547722
2.

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.

Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z.

Brain Res. 2010 Sep 17;1352:255-64. doi: 10.1016/j.brainres.2010.07.009. Epub 2010 Jul 13.

PMID:
20633539
3.

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.

Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B.

Oncogene. 2007 Jan 11;26(2):186-97. Epub 2006 Jul 3.

PMID:
16819506
4.

Multifaceted resistance of gliomas to temozolomide.

Bocangel DB, Finkelstein S, Schold SC, Bhakat KK, Mitra S, Kokkinakis DM.

Clin Cancer Res. 2002 Aug;8(8):2725-34.

5.
7.

In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.

Kil WJ, Cerna D, Burgan WE, Beam K, Carter D, Steeg PS, Tofilon PJ, Camphausen K.

Clin Cancer Res. 2008 Feb 1;14(3):931-8. doi: 10.1158/1078-0432.CCR-07-1856.

8.

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.

Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM.

Biochem Pharmacol. 2002 Apr 1;63(7):1219-28.

PMID:
11960598
9.

Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.

Conway GE, Casey A, Milosavljevic V, Liu Y, Howe O, Cullen PJ, Curtin JF.

Br J Cancer. 2016 Feb 16;114(4):435-43. doi: 10.1038/bjc.2016.12. Epub 2016 Feb 4.

10.

Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide.

Xu GW, Mymryk JS, Cairncross JG.

Int J Cancer. 2005 Aug 20;116(2):187-92.

11.

[Mechanism of temozolomide-induced anti-tumor effects on glioblastoma cells in vitro is via ROS-dependent SIRT1 signaling pathway].

Jiang Y, Sun Y, Yuan Y.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):734-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.004. Chinese.

PMID:
23291065
12.

Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment.

Jakubowicz-Gil J, Langner E, Bądziul D, Wertel I, Rzeski W.

Tumour Biol. 2013 Aug;34(4):2367-78. doi: 10.1007/s13277-013-0785-0. Epub 2013 Apr 12.

13.

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Tentori L, Leonetti C, Scarsella M, D'Amati G, Vergati M, Portarena I, Xu W, Kalish V, Zupi G, Zhang J, Graziani G.

Clin Cancer Res. 2003 Nov 1;9(14):5370-9.

14.

Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.

Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH.

Oncol Rep. 2006 Jul;16(1):33-9.

PMID:
16786120
15.
16.
17.

Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.

D'Alimonte I, Nargi E, Zuccarini M, Lanuti P, Di Iorio P, Giuliani P, Ricci-Vitiani L, Pallini R, Caciagli F, Ciccarelli R.

Purinergic Signal. 2015 Sep;11(3):331-46. doi: 10.1007/s11302-015-9454-7. Epub 2015 May 15.

18.

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.

Karpel-Massler G, Kast RE, Westhoff MA, Dwucet A, Welscher N, Nonnenmacher L, Hlavac M, Siegelin MD, Wirtz CR, Debatin KM, Halatsch ME.

J Neurooncol. 2015 Mar;122(1):21-33. doi: 10.1007/s11060-014-1688-7. Epub 2014 Dec 19.

PMID:
25524815
19.

Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.

Alexiou GA, Gerogianni P, Vartholomatos E, Kyritsis AP.

Cancer Invest. 2016 Nov 25;34(10):489-495. Epub 2016 Oct 21.

PMID:
27768402
20.

Effect of association of temozolomide with other chemotherapic agents on cell growth inhibition in glioma cell lines.

Balzarotti M, Ciusani E, Calatozzolo C, Croci D, Boiardi A, Salmaggi A.

Oncol Res. 2004;14(7-8):325-30.

PMID:
15301423

Supplemental Content

Support Center